Psychiatry and Neurology, Neurology · Los Angeles, CA
NPI
1528086824
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
300 Medical Plaza, #b200
Los Angeles, CA, 90095
Phone (310) 794-1195
Groups this clinician bills Medicare through
Medicare paid, 2024
$95K
6,412 services
Medicare patients, 2024
294
Average age 74
Drug cost, 2024
$4.0M
1,294 prescriptions
Company payments, 2025
$151
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Martina H Wiedau was code 99215 (office e&m - established), 140 times for 101 patients. In total Martina H Wiedau billed 6,412 services in 41 codes, and Medicare paid $95K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 140 | 101 | $136.29 | $19K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 81 | 64 | $12.92 | $1,046 |
| 99214 Office E&M - Established | Office | 78 | 59 | $96.70 | $7,543 |
| 99205 Office E&M - New | Office | 49 | 49 | $165.71 | $8,120 |
| 92522 Speech Therapy | Office | 33 | 24 | $82.45 | $2,721 |
| 94010 Pulmonary Function Testing | Office | 32 | 24 | $23.76 | $760 |
| 92610 Speech Therapy | Office | 28 | 22 | $74.55 | $2,087 |
| 99204 Office E&M - New | Office | 27 | 27 | $125.14 | $3,379 |
| 99223 Hospital E&M - Initial | Facility | 27 | 27 | $136.07 | $3,674 |
| 97166 PT/OT Evaluation | Office | 26 | 17 | $80.82 | $2,101 |
| 99233 Hospital E&M - Subsequent | Facility | 24 | 16 | $97.94 | $2,350 |
| 97162 PT/OT Evaluation | Office | 21 | 18 | $64.27 | $1,350 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 18 | 18 | $25.10 | $452 |
| 99443 Telephone Services | Office | 17 | 14 | $73.57 | $1,251 |
| 97165 PT/OT Evaluation | Office | 13 | 11 | $84.03 | $1,092 |
By year: 2022 $81K for 1,862 services; 2023 $78K for 3,218 services; 2024 $95K for 6,412 services.
Medicare prescription drug claims, 2024
In 2024, the drug Martina H Wiedau prescribed most often to Medicare patients was Radicava Ors (Edaravone), with 176 prescriptions and refills. In total Martina H Wiedau wrote 1,294 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Radicava Ors Edaravone | 176 | 176 | 23 | $2.5M |
| Gabapentin Generic | 103 | 242 | 39 | $3,708 |
| Donepezil Hcl Generic | 69 | 188 | 22 | $855 |
| Riluzole Generic | 67 | 171 | 22 | $14K |
| Memantine Hcl Generic | 57 | 168 | 20 | $4,204 |
| Sumatriptan Succinate Generic | 50 | 61 | Under 11 | $1,539 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 49 | 49 | Under 11 | $730K |
| Rizatriptan Rizatriptan Benzoate | 31 | 31 | Under 11 | $807 |
| Levetiracetam Generic | 31 | 80 | Under 11 | $1,341 |
| Primidone Generic | 31 | 86 | Under 11 | $1,369 |
| Pregabalin Generic | 31 | 39 | Under 11 | $948 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 26 | 64 | Under 11 | $886 |
| Lamotrigine Generic | 26 | 72 | Under 11 | $487 |
| Baclofen Generic | 23 | 57 | Under 11 | $552 |
| Emgality Pen Galcanezumab-Gnlm | 23 | 25 | Under 11 | $17K |
Brand drugs: - claims; generic drugs: 913 claims; opioid claims: 16.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Martina H Wiedau $151 ($151 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbvie Inc. with $112.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.